12,372 trials
Hypertension
Primary: Percentage Change From Baseline to End of Treatment for the Difference Between the Post-ischemia and Pre-ischemia Forearm Vascular Resistance (FVR).
Dentin Hypersensitivity
Primary: Hypersensitivity Tactile(Yeaple Probe) — 19.81; 13.94 units on a scale — p=0.05
Asthma
Primary: The Number of Participants With a Differential Response to the Three Step-up Therapies Based on Fixed Threshold Criteria for the Following Three Asthma Control Measures…
Myopia
Primary: High Contrast Visual Acuity — -0.04; -0.04 logMAR
Dementia of the Alzheimer's Type
Primary: Change From Baseline in Severe Impairment Battery (SIB) at Week 24 (LOCF) — -0.4; 2.2 Units on a scale — p=0.001
Dementia · Alzheimer's Disease
Primary: Number of Participants With Incident Dementia — 277; 246 Participants — p=0.21
Idiopathic Pulmonary Arterial Hypertension · Cardiomyopathy
Primary: Number of Participants With Reversible Pulmonary Hypertension (Vasoreactivity) — 28; 16 Participants
Coronary Arteriosclerosis · Acute Coronary Syndromes
Primary: Number of Subjects Reaching the Composite Endpoint of Cardiovascular (CV) Death, Nonfatal Myocardial Infarction (MI), or Nonfatal Stroke — 469; 565; 174; 216…
Chronic Obstructive Pulmonary Disease
Primary: Total Number of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations Per Patient-treatment Year — 0.75; 0.84; 1.14 Exacerbations
Heart Defects, Congenital · Heart Failure, Congestive
Primary: Weight-for-age Z-score at 14 Months of Age — -0.62; -0.42 standard deviation — p=0.28
Papillomavirus Infections
Primary: Number of Participants Who Seroconvert to HPV 6. — 109; 0 Participants
Benign Prostatic Hyperplasia
Primary: Number of Men With Treatment-emergent Dizziness — 9; 11 Participants — p=0.403
Dental Plaque
Primary: Triclosan Concentration in Dental Plaque — 0; 1.8 ppm levels of triclosan — p=0.05
Colorectal Cancer
Primary: Progression-Free Survival (Oxaliplatin) — 10.0; 11.4 Month — p=0.011
Gaucher Disease, Type 1
Primary: Change From Baseline to 12 Months in Hemoglobin Concentration for the 60 U/kg Treatment Group. — 2.429 g/dL — p=<0.0001